![](https://investorshub.advfn.com/uicon/170585.png?cb=1715106542)
Thursday, December 17, 2009 7:13:00 PM
I think we finally just lost the .36 technical floor due to weakness here and in the markets in general the last 3 months and seasoned traders know that support level is gone now so it is and will mover lower until enough new good news sets a new floor. Also the charts show a technical GAP in the chart from months back that is around .21-.24/share, which is where the stock maybe headed short term, and would make a good buy point. That gap should act as support, and possibly rally back up from there, unless some unexpected news arrives from left field soon.
I still have the original shares I bought at .70, holding for the long haul, and I bought a bunch more at .36 a while back and sold those around .42 to help cover the loss on the .70 shares, and I have orders in for .21 if we get their, just based on the chart Gap and the fact that super good news does not last forever. I do think, there is a good chance this stock could turn into a cash cow if China follows through and does all the manufacturing and R&D based on the patents, and starts paying license fees in a few years. Under that scenario TTEG would not need to dilute to raise huge amounts of cash. I do not consider this a buy, sell and run stock like many penny stocks, but as long as it is volatile, and drifting lower for now, it seems prudent to hold a small core position, and swing trade the highs and lows until it starts to see reportable profits, or hits a long term stable bottom....
Recent NVOS News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:30:34 PM
- Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 06/13/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:30:13 PM
- Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million • Business Wire • 06/06/2024 07:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 07:00:19 PM
- Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products • Business Wire • 06/05/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 07:00:34 PM
- Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note • Business Wire • 06/03/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 01:00:14 PM
- Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program • Business Wire • 05/31/2024 01:00:00 PM
- Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 05/30/2024 08:30:00 PM
- Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results • Business Wire • 04/15/2024 08:30:00 PM
- Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement • Business Wire • 04/11/2024 09:00:00 PM
- Novo Integrated Sciences Provides Update on Certain Current Actions and Events • Business Wire • 03/26/2024 06:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:05:40 PM
- Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. • Business Wire • 02/21/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 07:00:19 PM
- Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note • Business Wire • 02/20/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 07:00:26 PM
- Novo Integrated Sciences Appoints New President • Business Wire • 02/16/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:00:20 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 05:00:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/22/2024 09:31:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:30:12 PM
- Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results • Business Wire • 01/22/2024 09:30:00 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM